Placental Growth Factor Promotes Atherosclerotic Intimal Thickening and Macrophage Accumulation

Background—Placental growth factor (PlGF) has been implicated in the pathophysiological angiogenesis and monocyte recruitment that underlie chronic inflammatory disease, but its role in atherosclerosis has not been examined. We investigated the effects of exogenous PlGF, delivered by adenoviral gene transfer, on atherogenic intimal thickening and macrophage accumulation induced by collar placement around the rabbit carotid artery and examined the effects of PlGF deficiency on atherosclerosis in apolipoprotein E–deficient (apoE−/−) mice. Methods and Results—Periadventitial transfer of PlGF2-encoding adenoviruses significantly increased intimal thickening, macrophage accumulation, endothelial vascular cell adhesion molecule-1 expression, and adventitial neovascularization in the collared arteries of hypercholesterolemic rabbits and increased the intima-to-media ratio in rabbits fed a normal diet. Neointimal macrophages were associated with increased expression of the PlGF receptor Flt-1. The size and macrophage content of early atherosclerotic lesions were reduced in mice deficient in both apoE and PlGF compared with apoE-deficient mice. Conclusions—Local adenoviral PlGF2 delivery promotes atherogenic neointima formation in hypercholesterolemic rabbits, and PlGF is required for macrophage infiltration in early atherosclerotic lesions in apoE−/− mice. These findings support a novel role for PlGF in the pathogenesis of atherosclerotic disease.

[1]  N. Ferrara,et al.  Angiogenesis-Dependent and Independent Phases of Intimal Hyperplasia , 2004, Circulation.

[2]  I. Zachary,et al.  Vascular Endothelial Growth Factor Gene Transfer Inhibits Neointimal Macrophage Accumulation in Hypercholesterolemic Rabbits , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[3]  A. Luttun,et al.  Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth , 2004, Circulation.

[4]  I. Zachary.  VEGF signalling: integration and multi-tasking in endothelial cell biology. , 2003, Biochemical Society transactions.

[5]  N. Perelman,et al.  Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. , 2003, Blood.

[6]  Christoph Dehio,et al.  Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 , 2003, Nature Medicine.

[7]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[8]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[9]  P. Carmeliet,et al.  VEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic: Evidence for a Monocyte-Mediated Mechanism , 2003, Circulation research.

[10]  A. Luttun,et al.  Bone marrow transplantation abolishes inhibition of arteriogenesis in placenta growth factor (PlGF) -/- mice. , 2003, Journal of molecular and cellular cardiology.

[11]  Rachel Jones.  Ecstasy danger hits the headlines , 2002, Nature Reviews Neuroscience.

[12]  S. Donnini,et al.  Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1. , 2002, Cardiovascular research.

[13]  S. Rafii,et al.  Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment , 2002, Nature Medicine.

[14]  S. Rafii,et al.  Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.

[15]  M. Cybulsky,et al.  Adhesion of Monocytes to Arterial Endothelium and Initiation of Atherosclerosis Are Critically Dependent on Vascular Cell Adhesion Molecule-1 Gene Dosage , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[16]  D. Mukhopadhyay,et al.  Vascular Permeability Factor (VPF)/Vascular Endothelial Growth Factor (VEGF) Receptor-1 Down-modulates VPF/VEGF Receptor-2-mediated Endothelial Cell Proliferation, but Not Migration, through Phosphatidylinositol 3-Kinase-dependent Pathways* , 2001, The Journal of Biological Chemistry.

[17]  M. Cybulsky,et al.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.

[18]  Till Acker,et al.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.

[19]  K. Shitara,et al.  Surface Marker for the Lineage of Monocyte-macrophages in Humans Flt-1, Vascular Endothelial Growth Factor Receptor 1, Is a Novel Cell , 2022 .

[20]  M. Cybulsky,et al.  Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. , 1999, Circulation research.

[21]  J. Keiser,et al.  Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. , 1998, Circulation research.

[22]  M. Laakso,et al.  VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. , 1997, Human gene therapy.

[23]  E. Donetti,et al.  Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. , 1997, Human gene therapy.

[24]  G. Breier,et al.  The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.

[25]  G. D. De Meyer,et al.  The endothelium during cuff-induced neointima formation in the rabbit carotid artery. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  R. M. Lee,et al.  Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. , 1990, Atherosclerosis.

[27]  A. Luttun,et al.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.

[28]  J. Beesley,et al.  Ultrastructural Assessment of Lesion Development in the Collared Rabbit Carotid Artery Model , 1992 .